These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11725078)

  • 1. Camptothecin: A Promising Antiretroviral Drug.
    Pantazis P
    J Biomed Sci; 1996 Jan; 3(1):14-19. PubMed ID: 11725078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of retrovirus-induced disease in mice by camptothecin.
    Priel E; Aflalo E; Chechelnitsky G; Benharroch D; Aboud M; Segal S
    J Virol; 1993 Jun; 67(6):3624-9. PubMed ID: 8388515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency virus (HIV-1) replication in vitro by noncytotoxic doses of camptothecin, a topoisomerase I inhibitor.
    Priel E; Showalter SD; Blair DG
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):65-72. PubMed ID: 1707642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camptothecin analogues with enhanced antitumor activity at acidic pH.
    Adams DJ; Dewhirst MW; Flowers JL; Gamcsik MP; Colvin OM; Manikumar G; Wani MC; Wall ME
    Cancer Chemother Pharmacol; 2000; 46(4):263-71. PubMed ID: 11052623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camptothecin post-treatments inhibit the biochemical events linked to the tumor-promoting component of carcinogenesis in mouse epidermis in vivo.
    Gao XM; Perchellet EM; Davis AW; Newell SW; Chen G; Hua DH; Perchellet JP
    Int J Cancer; 1996 May; 66(4):496-505. PubMed ID: 8635865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.
    Eng WK; McCabe FL; Tan KB; Mattern MR; Hofmann GA; Woessner RD; Hertzberg RP; Johnson RK
    Mol Pharmacol; 1990 Oct; 38(4):471-80. PubMed ID: 2172765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic effects of camptothecin analogues 9-amino-20(S)-camptothecin, topotecan, and CPT-11 studied in the mouse cornea model.
    O'Leary JJ; Shapiro RL; Ren CJ; Chuang N; Cohen HW; Potmesil M
    Clin Cancer Res; 1999 Jan; 5(1):181-7. PubMed ID: 9918217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties.
    Lesueur-Ginot L; Demarquay D; Kiss R; Kasprzyk PG; Dassonneville L; Bailly C; Camara J; Lavergne O; Bigg DC
    Cancer Res; 1999 Jun; 59(12):2939-43. PubMed ID: 10383158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.
    Tamura H; Kohchi C; Yamada R; Ikeda T; Koiwai O; Patterson E; Keene JD; Okada K; Kjeldsen E; Nishikawa K
    Nucleic Acids Res; 1991 Jan; 19(1):69-75. PubMed ID: 1849260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody.
    Sugimoto Y; Tsukahara S; Oh-hara T; Isoe T; Tsuruo T
    Cancer Res; 1990 Nov; 50(21):6925-30. PubMed ID: 2170010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water-insoluble camptothecin analogues as potential antiviral drugs.
    Pantazis P; Han Z; Chatterjee D; Wyche J
    J Biomed Sci; 1999 Jan; 6(1):1-7. PubMed ID: 9933736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance.
    Kanzawa F; Sugimoto Y; Minato K; Kasahara K; Bungo M; Nakagawa K; Fujiwara Y; Liu LF; Saijo N
    Cancer Res; 1990 Sep; 50(18):5919-24. PubMed ID: 2168285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication-dependent and -independent camptothecin cytotoxicity of seven human colon tumor cell lines.
    Borovitskaya AE; D'Arpa P
    Oncol Res; 1998; 10(5):271-6. PubMed ID: 9802062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin.
    Kapoor R; Slade DL; Fujimori A; Pommier Y; Harker WG
    Oncol Res; 1995; 7(2):83-95. PubMed ID: 7579731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11].
    Matsumoto Y; Fujiwara T; Honjo Y; Sasaoka N; Tsuchida T; Nagao S
    Noshuyo Byori; 1994; 11(1):59-64. PubMed ID: 8162152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current status of camptothecin analogues as antitumor agents.
    Slichenmyer WJ; Rowinsky EK; Donehower RC; Kaufmann SH
    J Natl Cancer Inst; 1993 Feb; 85(4):271-91. PubMed ID: 8381186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I.
    Das BB; Sen N; Roy A; Dasgupta SB; Ganguly A; Mohanta BC; Dinda B; Majumder HK
    Nucleic Acids Res; 2006; 34(4):1121-32. PubMed ID: 16488884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nitidine chloride and camptothecin on the growth of Babesia and Theileria parasites.
    Tayebwa DS; Tuvshintulga B; Guswanto A; Nugraha AB; Batiha GE; Gantuya S; Rizk MA; Vudriko P; Sivakumar T; Yokoyama N; Igarashi I
    Ticks Tick Borne Dis; 2018 Jul; 9(5):1192-1201. PubMed ID: 29730263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camptothecin analogs in malignant gliomas: comparative analysis and characterization.
    Sampath P; Amundson E; Wall ME; Tyler BM; Wani MC; Alderson LM; Colvin M; Brem H; Weingart JD
    J Neurosurg; 2003 Mar; 98(3):570-7. PubMed ID: 12650430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis.
    Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A
    Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.